{"schema_version":"secwatch.filing_event.v1","accession":"0001842952-23-000070","form_type":"8-K","ticker":"CNTX","cik":"0001842952","company_name":"Context Therapeutics Inc.","filed_at":"2023-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.138522+00:00","generated_at":"2026-06-13T21:47:14.663980+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Context Therapeutics regains Nasdaq minimum bid price compliance","bullets":["Non-compliance with Minimum Bid Price Rule first disclosed on Jan 24, 2023; initial cure period ran to July 24, 2023.","On June 15, 2023, Nasdaq confirmed the company's common stock had a closing bid price of $1.00+ for 10 consecutive business days.","Nasdaq considers the matter closed; the company has regained compliance with Listing Rule 5550(a)(2)."],"urls":{"canonical":"https://secwatch.observer/filing/0001842952-23-000070","json":"https://secwatch.observer/filing/0001842952-23-000070.json","markdown":"https://secwatch.observer/filing/0001842952-23-000070.md","text":"https://secwatch.observer/filing/0001842952-23-000070.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842952/000184295223000070/0001842952-23-000070-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842952/000184295223000070/cntx-20230615.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T21:47:14.663980+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}